There is no doubt that CRISPR and CAR-T cell therapy are breakthroughs in the medical field. But because they are still in their initial stages, they come with a million-dollar price tag. What does the future hold for such emerging trends that interweave different fields to pave the way for improving people’s lives, if the outcomes are but accessible to a handful?
